
The study resulted in several findings on cannabis use and connections to physical and mental health conditions.
Cannabis Unearthed: Forensic Analysis Reveals Cannabis in 17th Century Human Bones
Analyzing the Impact of Recreational Cannabis Legalization on Young Adult Cannabis Use

The study resulted in several findings on cannabis use and connections to physical and mental health conditions.

This blog installment looks at the use of cannabis for pets. Topics covered include the history of cannabis use in veterinary medicine, current laws on cannabis for pets, market size and segment, reported experiences from both pet owners and veterinarians, and pet toxicology.

The University of Buffalo has received a grant from the NIH National Cancer Institute to research cannabis’s medicinal effect on cancer immunotherapy treatment.

Our sister publication, Nutritional Outlook, recently published an article about how hair health could turn into another promising market for CBD.

A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.

A recent study conducted in Canada with over 1,200 participants has found that psilocybin may significantly alleviate psychological distress resulting from childhood trauma, particularly benefitting those with more severe adversity, suggesting its therapeutic potential in addressing long-lasting trauma-related symptoms.

This blog installment takes a look at the mind-body connection and how the endocannabinoid system (ECS) plays a key role. Topics covered include the gut, the vagus nerve, the gut-brain axis, and more.

The 18-month trial will study the effects of a cannabis extract as part of treatment for brain cancer.

Cannabis Science Conference Fall was held in Providence, Rhode Island from September 20-22, 2023. Here we provide highlights from this exciting event.

A study found that cannabis users that were infected by the COVID-19 virus, experienced ‘better outcomes and mortality’ than non-cannabis users.

Various efforts to attract non-white participants to the study have not succeeded, putting the study in jeopardy.

The study’s principal investigator recently provided more information about the new trial compared to a previous one in 2017.

In this new interview series, we sit down with several speakers from 2023 Cannabis Science Conference events to learn about their expertise and backgrounds in the cannabis industry. Join us to learn more about Dr. Peter Grinspoon, Jini Glaros, Dr. Miyabe Shields, and Adam Jacques.

A recent study in Molecular Psychiatry suggests CBD use during pregnancy may harm fetal brain development, posing a cognitive risk.

Let’s meet Riley Kirk, PhD, cannabis and natural product chemist, cannabis educator, and cannabis research scientist.

A recent study sought to examine the occurrence of cannabis use disorder in patients and recreational users, specifically in a state with legal cannabis access.


Let’s meet Miyabe Shields, PhD, a queer and neurodivergent stoner scientist and avid psychonaut with more than 13 years of experience in academic and industrial research.

This column reviews a study published by cannabis industry design and construction professionals and describes the impact of energy regulations affecting heating, ventilation, and air conditioning (HVAC) system selection in cannabis production facilities.

This article delves into the aspects of horticultural light intensity and spectra as well as their relative influence on cannabis photosynthesis, photomorphogenesis, and overall yield.

See the program overview for the upcoming Cannabis Science Conference Fall in Providence, Rhode Island September 20-22nd.

A recently published study tracked American adults’ opinions over several years on smoking cannabis compared to smoking tobacco.

The small study will begin later this year and seeks to further understand brain function in gambling disorder.

Our sister publication, dvm360, recently published breakthrough research from a study involving CBD+CBDA oil as a potential treatment for atopic dermatitis in dogs.

Pharmaceutical developer Oxford Cannabinoid Technologies recently described the potential of its latest cannabinoid-based immunotherapy treatment.